Neuromyelitis Optica Spectrum Disorder: From Basic Research to Clinical Perspectives

Area of Science:

• Neuroimmunology
• Central Nervous System Inflammatory Disorders

Background:

• Neuromyelitis optica spectrum disorder (NMOSD) is a severe autoimmune inflammatory disease of the central nervous system.
• It is characterized by autoantibodies targeting the aquaporin-4 water channel protein on astrocytes.
• Recent research has significantly advanced the understanding of NMOSD's diverse phenotypes, biomarkers, and inflammatory pathways.

Purpose of the Study:

• To provide an updated review of recent studies on Neuromyelitis optica spectrum disorder (NMOSD).
• To cover key aspects including pathophysiology, biomarkers, diagnostic tools, and animal models.

Main Methods:

• Review of recent scientific literature and clinical trial data on NMOSD.
• Analysis of studies focusing on disease mechanisms, biomarkers (cytokines), and diagnostic technologies (OCT).
• Comparison of various animal models used in NMOSD research.

Main Results:

• Identification of distinct NMOSD phenotypes and complex inflammatory cascades.
• Evaluation of serum and cerebrospinal fluid cytokines as potential biomarkers.
• Assessment of ocular coherence tomography (OCT) for clinical utility.
• Comparison of the relevance and limitations of different NMOSD animal models.

Conclusions:

• Significant progress has been made in understanding NMOSD pathogenesis and identifying potential therapeutic targets.
• Biomarkers and advanced imaging like OCT are crucial for diagnosis and monitoring.
• Ongoing research and clinical trials are paving the way for novel treatments for NMOSD relapses.